Literature DB >> 23480012

[Benefits of epidural analgesia in major neonatal surgery].

J Gómez-Chacón1, J Encarnación, M Couselo, L Mangas, A Domenech, C Gutiérrez, C García Sala.   

Abstract

The aim of this paper is to describe and evaluate the benefits of epidural anesthesia in major surgery neonatal. We have performed a matched case-control (2:1) study of patients undergoing neonatal major surgery (NMSs) who received intra-and postoperative epidural anesthesia (EA) and controls with conventional general anesthesia. The matching criteria were age, weight and baseline pathology. EA was administered by caudal puncture and epidural catheter placed with ultrasound support. Levobupivacaine was selected as anesthetic drug. The time to extubation, intestinal transit time, type of analgesia and complications were studied. This study is based on 11 cases (2 esophageal atresia, 2 diaphragmatic hernias, 1 necrotizing enterocolitis, 3 intestinal atresia, 2 anorectal malformation and 1 bladder exstrophy) and 22 controls. We observed statistically significant differences in time to extubation (95% CI OR 12 1.99 to 72.35; Chi2 p = 0.004, Mann U Whytney p = 0.013) and intestinal transit time (Mann Whitney U p < 0.001, 100 Or, 95% CI 8.06-1 239; Chi2 p < 0.0001). There were no complications from epidural analgesia. Therefore we believe that the intra-and postoperative EA helps improve postoperative management in neonates and should be preferred in centers where this technique is available.

Entities:  

Mesh:

Year:  2012        PMID: 23480012

Source DB:  PubMed          Journal:  Cir Pediatr        ISSN: 0214-1221


  2 in total

Review 1.  Epidural anesthesia and analgesia in the neonate: a review of current evidences.

Authors:  Souvik Maitra; Dalim Kumar Baidya; Dilip K Pawar; Mahesh Kumar Arora; Puneet Khanna
Journal:  J Anesth       Date:  2014-02-13       Impact factor: 2.078

2.  [Regional anesthesia procedures in childhood: Austrian interdisciplinary recommendations on pediatric perioperative pain management].

Authors:  B Messerer; M Platzer; C Justin; M Vittinghoff
Journal:  Schmerz       Date:  2014-02       Impact factor: 1.107

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.